Abstract
Acute severe asthma calls for aggressive and early therapy of a multifaceted and all-inclusive approach (Fig.2). Therapy merely begins in the ED and manifold distinct issues need to find consideration during ongoing hospital care. Currently, β-agonists, anti-cholinergic agents, and corticosteroids remain the mainstay of therapy. Methylxanthines and magnesium may find consideration in carefully selected patients. Multiple new therapeutic avenues, such as the anti-leukotriene drugs, seem promising and future studies will hopefully extend our armamentarium against life threatening complication of a common disease. Asthma education begun in the hospital may provide the platform for preventing severe acute exacerbations and hospitalization.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 357-383 |
| Number of pages | 27 |
| Journal | Clinical Reviews in Allergy and Immunology |
| Volume | 20 |
| Issue number | 3 |
| DOIs | |
| State | Published - 2001 |
Fingerprint
ASJC Scopus subject areas
- Immunology and Allergy
Cite this
Pharmacologic treatment of the adult hospitalized asthma patient. / Kreutzer, M. L.; Louie, Samuel.
In: Clinical Reviews in Allergy and Immunology, Vol. 20, No. 3, 2001, p. 357-383.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Pharmacologic treatment of the adult hospitalized asthma patient
AU - Kreutzer, M. L.
AU - Louie, Samuel
PY - 2001
Y1 - 2001
N2 - Acute severe asthma calls for aggressive and early therapy of a multifaceted and all-inclusive approach (Fig.2). Therapy merely begins in the ED and manifold distinct issues need to find consideration during ongoing hospital care. Currently, β-agonists, anti-cholinergic agents, and corticosteroids remain the mainstay of therapy. Methylxanthines and magnesium may find consideration in carefully selected patients. Multiple new therapeutic avenues, such as the anti-leukotriene drugs, seem promising and future studies will hopefully extend our armamentarium against life threatening complication of a common disease. Asthma education begun in the hospital may provide the platform for preventing severe acute exacerbations and hospitalization.
AB - Acute severe asthma calls for aggressive and early therapy of a multifaceted and all-inclusive approach (Fig.2). Therapy merely begins in the ED and manifold distinct issues need to find consideration during ongoing hospital care. Currently, β-agonists, anti-cholinergic agents, and corticosteroids remain the mainstay of therapy. Methylxanthines and magnesium may find consideration in carefully selected patients. Multiple new therapeutic avenues, such as the anti-leukotriene drugs, seem promising and future studies will hopefully extend our armamentarium against life threatening complication of a common disease. Asthma education begun in the hospital may provide the platform for preventing severe acute exacerbations and hospitalization.
UR - http://www.scopus.com/inward/record.url?scp=0035019961&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035019961&partnerID=8YFLogxK
U2 - 10.1385/CRIAI:20:3:357
DO - 10.1385/CRIAI:20:3:357
M3 - Article
C2 - 11413904
AN - SCOPUS:0035019961
VL - 20
SP - 357
EP - 383
JO - Clinical Reviews in Allergy and Immunology
JF - Clinical Reviews in Allergy and Immunology
SN - 1080-0549
IS - 3
ER -